Genetic therapy for transplant vascular sclerosis

By Bennett C.F.   Stepkowski S.M.  

Transplant Immunology, Vol. 5, Iss. 4, 1997-12 ,pp. : 299-302

Elsevier

Access to resources Recommend Favorite

Contribution of lipids to the pathogenesis of transplant vascular sclerosis

By Wilson J.E.   Wood S.   McDonald P.   Kenyon J.   Dong C.   McManus B.M.  

Transplant Immunology, Vol. 5, Iss. 4, 1997-12 ,pp. : 247-250

Elsevier

Access to resources Recommend Favorite

Role of the antibody in the pathogenesis of transplant vascular sclerosis: a hypothesis

By Wewers M.D.   Marsh C.B.  

Transplant Immunology, Vol. 5, Iss. 4, 1997-12 ,pp. : 283-288

Elsevier

Access to resources Recommend Favorite

Vascular cells have limited capacities to activate and differentiate T cells: Implications for transplant vascular sclerosis

By Pober J.S.   Ma W.   Biedermann B.   Libby P.  

Transplant Immunology, Vol. 5, Iss. 4, 1997-12 ,pp. : 251-254

Elsevier

Access to resources Recommend Favorite

CMV as an Exacerbating Agent in Transplant Vascular Sclerosis: Potential Immune-Mediated Mechanisms Modelled In Vitro

By Waldman W.J.   Adams P.W.   Knight D.A.   Sedmak D.D.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1545-1546

Elsevier

Access to resources Recommend Favorite